A Science and Technology Blog
Information shared by the three stakeholders — NEJM, NIAID and Gilead — on critical issues about whether the drug’s ability to reduce mortality is statistically significant and which category of…
Interim results of Moderna’s phase-1 human clinical trial of novel coronavirus vaccine (mRNA-1273) shows the vaccine is safe. The vaccine was also able to elicit neutralizing antibodies. Interim results of…
The journal that published a paper claiming that hydroxychloroquine had “significant” success in treating COVID-19 patients now has an expression of “concerns” published by its publisher. On March 23, ICMR…
Based on weak evidence, ICMR has recommended hydroxychloroquine as prophylaxis by healthcare workers taking care of COVID-19 cases and asymptomatic household contacts of confirmed cases. No other drug approving agency…
More than 50 years after the infectious pathogen, rubella virus, was identified as the cause of an epidemic of congenital defects, the Centres for Disease Control and Prevention (CDC) in…
Published in The Hindu on September 10, 2009 The world’s first clinical trial of H1N1 influenza vaccine in pregnant women will be launched this week in the U.S. Pregnant women…
Published in The Hindu on September 12, 2009 The safety of 2009 influenza A(H1N1) vaccines that are undergoing clinical trials in different countries has got a shot in the arm.…
